Navigation Links
Acceleron Pharma's ACE-031 Increases Muscle Mass and Strength in,Preclinical Studies

LUCCA, Italy--(BUSINESS WIRE)--May 14, 2007 - Acceleron Pharma, Inc., a biopharmaceutical company developing therapeutics for the treatment of musculoskeletal, metabolic and cancer-related diseases, today announced results of a preclinical study with ACE-031 that demonstrated the ability of the compound to increase muscle mass and strength in normal mice and in murine models of muscular dystrophy. ACE-031 inhibits negative regulators of muscle to increase muscle mass and strength as a potential treatment for neuromuscular diseases and cancer-related muscle loss. The data was presented on Sunday, May 13 at the Gordon Research Conference on Myogenesis in Lucca, Italy.

"Acceleron is encouraged by the significant outcomes and positive data generated by ACE-031 spanning numerous preclinical models of muscle loss", said Jas Seehra, Ph.D., Chief Scientific Officer of Acceleron. "ACE-031 and related Acceleron compounds consistently demonstrate substantial increases in skeletal muscle mass and strength."

ACE-031, a protein therapeutic based on the activin receptor type IIB (ActRIIB), is the first of several compounds Acceleron is developing for the treatment of diseases involving the loss of muscle mass, strength and function. ActRIIB binds to myostatin (GDF-8) and other negative regulators of muscle mass and strength. Over-expression of myostatin has been shown to cause a loss in muscle mass and strength, and inhibition of myostatin results in the selective increase in skeletal muscle mass and strength. In preclinical models, ACE-031 increased skeletal muscle mass and strength in disease models of amyotrophic lateral sclerosis (ALS), muscular dystrophy, glucocorticoid-induced muscle loss and age-related muscle loss (sarcopenia). ACE-031 offers the potential for an entirely new type of therapy for the treatment of various muscle wasting conditions.

"The clinical potential of ACE-031 to selectively increase
'"/>




Page: 1 2 3

Related medicine technology :

1. Accelreon Pharmas ACE-031Shown to Increase Muscle Mass in Preclinical Studies
2. Integrated BioPharmas Proprietary Vaccine Technology Achieves Strong Positive Results
3. Rapid HIV Testing Increases Possibility of Treatment
4. ProtoKinetixs AAGP Dramatically Increases Recovery Rate of Cryopreserved Stem Cells
5. MabThera Significantly Increases Survival of Lymphoma Patients Regardless of Chemotherapy Regimen
6. Researchers Discover a Common Variation in a Gene Segment that Increases the Risk for Prostate Cancer
7. New Data on Market-Leading Velcade (Bortezomib) for Injection Further Strengthen Role in Previously Treated Multiple Myeloma
8. SPIRIT Clinical Data Reaffirm Strength of Taxus and Promus Drug-Eluting Coronary Stent Systems
9. EntreMeds Aurora Kinase Inhibitor Induces Tumor Regression in Preclinical Models
10. Data Presented at AACR Meeting Shows Peregrines Immunocytokine Fusion Proteins Reduce Growth of B-Cell Lymphoma Tumors by 85% in Preclinical Studies
11. Data Presented at AACR Meeting Shows Bavituximab Equivalent Plus Docetaxel Reduces Growth of Both Hormone-Dependent and Hormone-Independent Prostate Cancer by Up to 94 Percent in Preclinical Studies
Post Your Comments:
(Date:9/1/2015)... DUBLIN , Aug. 31, 2015 ... the addition of the "Introduction to Veterinary ... to their offering. This course ... a good introduction to those concerned with Veterinary ... experienced personnel who reqire a better understanding of ...
(Date:9/1/2015)... Egalet Corporation (Nasdaq: EGLT ) ... on discovering, developing, and commercializing innovative pain treatments, ... data on SPRIX ® (ketorolac tromethamine) Nasal ... candidate, and Egalet-002, an abuse-deterrent, extended-release, oral oxycodone ... to be held September 8 to 12 in ...
(Date:9/1/2015)... , Sept. 1, 2015  Based on ... management market, Frost & Sullivan recognizes Pie ... Frost & Sullivan Award for Technology Leadership. ... has designed innovative and easy-to-use imaging solutions—its ... and reproducible quantitative results for cardiovascular diagnosis ...
Breaking Medicine Technology:Introduction to Veterinary Pharmacovigilance Seminar (London, UK - September 23-24) 2Egalet Announces Scientific Presentations at PainWeek 2015 Meeting 2Egalet Announces Scientific Presentations at PainWeek 2015 Meeting 3Egalet Announces Scientific Presentations at PainWeek 2015 Meeting 4Egalet Announces Scientific Presentations at PainWeek 2015 Meeting 5Egalet Announces Scientific Presentations at PainWeek 2015 Meeting 6Frost & Sullivan Applauds Pie Medical Imaging for Highly Innovative Quantitative Software for Cardiovascular Diagnosis 2Frost & Sullivan Applauds Pie Medical Imaging for Highly Innovative Quantitative Software for Cardiovascular Diagnosis 3Frost & Sullivan Applauds Pie Medical Imaging for Highly Innovative Quantitative Software for Cardiovascular Diagnosis 4Frost & Sullivan Applauds Pie Medical Imaging for Highly Innovative Quantitative Software for Cardiovascular Diagnosis 5
... Caliper Life Sciences, Inc. (Nasdaq: ... announced a co-marketing agreement which will leverage Covaris, ... microfluidics technologies to develop automated workflows for next ... suite of solutions for library construction, sample analysis, ...
... Pharmaceuticals, Inc. (Nasdaq: AVNR ) today announced that company ... in March. Citi 2011 Global Healthcare Conference ... Tuesday March 1, 2011 Presentation time: 8:00am ET ... Location: Boston Marriott, Boston, MA Presentation date: Tuesday March ...
Cached Medicine Technology:Caliper and Covaris Establish Co-Marketing Agreement to Simplify Next Generation Sequencing 2Caliper and Covaris Establish Co-Marketing Agreement to Simplify Next Generation Sequencing 3
(Date:9/1/2015)... ... September 01, 2015 , ... e-Spirit Inc., a leading supplier ... FirstSpirit Content Management System with new capabilities and enhancements designed to support the ... will be well on their way to achieving digital transformation with less time ...
(Date:9/1/2015)... ... 2015 , ... The FSH Society , the Massachusetts-based charity that has ... be the beneficiary of a collection of fundraising events this fall. From Boston to ... FSH Society and further FSHD research. , The list of 2015 fall ...
(Date:9/1/2015)... ... September 01, 2015 , ... METTLER ... Instruments in accordance with GMP requirements“ , featuring Ed Szczesny (Quality Assurance, Rhodes ... at 11:00 EDT (15:00 GMT). , Calibration, qualification, and the appropriate level ...
(Date:9/1/2015)... (PRWEB) , ... September 01, 2015 , ... ... date, more than 1,500 investor-families have received permanent green cards (I-829 petition approval) ... , The I-829 petition is the final step of the EB-5 visa process ...
(Date:9/1/2015)... ... 2015 , ... Situations requiring fast, easy-to-understand business and personal ... time for everyone involved. These occasions highlight the value of a professional translation ... has real people available to handle any translation assignment at any time of ...
Breaking Medicine News(10 mins):Health News:e-Spirit boosts Corporate Content Cloud initiative with release of FirstSpirit 5.2 2Health News:e-Spirit boosts Corporate Content Cloud initiative with release of FirstSpirit 5.2 3Health News:FSH Society Beneficiary of Variety of Fall Fundraising Events 2Health News:FSH Society Beneficiary of Variety of Fall Fundraising Events 3Health News:Live Webinar from Pharmaceutical Technology and METTLER TOLEDO on Calibration and Qualification of Laboratory Instruments 2Health News:CanAm Enterprises Reaches Another Milestone with More Than 1,500 I-829 Petition Approvals 2Health News:Universal Translation Services Provides Quality Translations 24 Hours a Day Including Weekends 2Health News:Universal Translation Services Provides Quality Translations 24 Hours a Day Including Weekends 3
... leukemia cells are thought to be inhabited by a rather ... attached// together in a pattern which is exactly the opposite ... is far removed from the theory prescribed in the molecular ... shift in the original thinking that relied on the information ...
... University of Kentucky being claims to one day change the ... to open up blocked arteries that feed the heart. ... author of the study that is to appear in the ... claimed that the drug ‘Enoxaparin’, that has been studied has ...
... 8 that treatment for a broad range of food allergies ... found// treatments by altering the proteins in the food that ... system. ,"Therapies for food allergy will be on ... Ree, of the University of Amsterdam, who is leading work ...
... Morbid obesity may have a deleterious effect on young, ... that obesity in toddlers is linked to lower IQ ... obesity with metabolic problems like diabetes, high cholesterol and ... Driscoll, a professor of pediatric genetics at the University ...
... in New Zealand are failing to get regular mammograms ... reports.// ,Breast Cancer Aotearoa Coalition Deputy Chairwoman ... the eligible women have taken the offer for free ... the increased waiting times are responsible for this. Mammograms ...
... Christchurch surgeon has put forth the idea that it would ... that had earlier been opposed and led to the// removal ... ,The Canterbury District Health Board had removed the patients from ... comply with the Health ministry policy. Nearly Seventy-four of the ...
Cached Medicine News:Health News:Enoxaparin To Become The Standard Treatment During Procedures For Blocked Arteries 2Health News:Cure for food allergies is less than a decade away 2Health News:Obesity Takes its Toll on IQ of Toddlers 2
... quick and easy automated refill system ... space on your laboratory bench and ... easy-to-use, one-hand system, you only need ... of Diamond Tips. All sizes of ...
... TowerPack is an innovative, quick ... Diamond Tips. Use 60% less space ... less plastic. With this amazingly easy-to-use, ... box for the whole range of ...
10 L, Racked, 96 tips/rack Extended length pipette tips recommended for 5 and 10 L pipettes....
This pipette tip facilitates the loading of samples onto polyacrylamide gels for DNA sequencing. The Geloader Tip has a 15 mm capillary with a defined diameter of less than 0.3 mm. The flexibility of...
Medicine Products: